FLOTEK INDUSTRIES INC/CN/ (FTK) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund opening new positions and 1 fund adding versus the previous quarter. Insiders were net sellers over the last 90 days ($34.3M bought vs $60.5M sold). Latest close $25.22 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 17, 2026 · Congress to Nov 16, 2026.
Polen Capital Management · First Eagle Investment Management — 2 tracked funds hold FTK. See all holders.
Insiders bought on the open market (1 purchase, $34.3M) vs 3 sales ($60.5M). Latest buy: Sep 11, 2026. Insider trading
Orion S.A. (OEC) · Element Solutions Inc (ESI) · ASP Isotopes Inc. (ASPI) · CABOT CORP (CBT) · Merck & Co., Inc. (MRK) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Polen Capital Management | 0.04% | 195,504 | ADDED (+607.3%) Q3 filed Nov 13 |
| First Eagle Investment Management | 0.01% | 293,242 | NEW Q3 filed Nov 10 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +5.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 114 of 8,857 filers |
| Long-only filers among them | 113 |
| Change vs 2026 Q1 | +13 net · 113 entered · 100 exited |
| Shares reported, all filers | 12,283,875 |
| Reported value, all filers | $290.2M |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Miscellaneous Chemical Products (SIC 2890) |
| Revenue · FY2025 | $237.3M |
| Net income · FY2025 | $30.5M |
| Total assets · FY2025 | $220.0M |
| Shares outstanding | 36,220,429 |
| Market cap (at latest close) | $913.5M |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 3, 2026.
| Shares short · Oct 15, 2026 | 4,248,686 |
| Share of shares outstanding | 11.73% |
| Days to cover | 9.12 |
Shares short at recent settlements — Jul 31, 2026: 2.8M · Aug 14, 2026: 2.8M · Aug 31, 2026: 3.4M · Sep 15, 2026: 3.8M · Sep 30, 2026: 3.8M · Oct 15, 2026: 4.2M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 3, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 4K · Aug 14, 2026: 0 · Aug 31, 2026: 1K · Sep 15, 2026: 1K · Sep 30, 2026: 21 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 3, 2026.
1 insider bought on the open market in the last 90 days (1 purchase, $34.3M), against 3 sales by 2 insiders ($60.5M). Latest buy: Sep 11, 2026.
$1M+ open-market buySource: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| Wilks Matthew · 1,319,493 shares on Sep 11, 2026 · filed Sep 15, 2026 | $26.01 | -11.6% (close Sep 16, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Sep 16, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Agadi Harshavardhan V | Sell | 6,750 | $25.02 | $168.9K | SEC filing | |
| Nov 13, 2026 | Agadi Harshavardhan V | Sell | 15,000 | $25.27 | $379.0K | SEC filing | |
| Sep 11, 2026 | Wilks Matthew | Buy | 1,319,493 | $26.01 | $34.3M | SEC filing | |
| Sep 11, 2026 | ProFrac GDM, LLC | Sell | 2,306,806 | $26.01 | $60.0M | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| May 18, 2026 | CLEMENT JAMES BOND | Officer | 12,554 | $257.4K | May 18, 2026 | SEC filing |
| Nov 13, 2025 | Agadi Harshavardhan V | Director | 66,956 | $1.0M | Nov 13, 2025 | SEC filing |
| Aug 14, 2025 | James B Clement | Chief Financial Officer | 45,732 | $582.6K | Aug 13, 2025 | SEC filing |
| Aug 14, 2025 | Ryan Ezell | Chief Executive Officer | 87,187 | $1.1M | Aug 14, 2025 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Sep 15, 2026 | SCHEDULE 13D/A | -11.6% (close Sep 16, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Sep 16, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | ProFrac Holding Corp. | SC 13D/A | 20,937,915 | 54.5% | Sep 11, 2026 | SEC filing |
| May 29, 2025 | ProFrac Holding Corp. | SC 13D/A | 23,244,721 | 61.1% | May 29, 2025 | SEC filing |
| Apr 30, 2025 | ProFrac Holding Corp. | SC 13D/A | 17,244,721 | 53.9% | Apr 28, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Miscellaneous Chemical Products (SIC 2890). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Insiders
· Large Insider Buys — Last 90 days: a single buy trade of $1M or more
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· Top Relative Strength — Top 20% of the universe by 6-month return
Red Flags
· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10
Key figures
· Large Insider Buys — Buy value: $34.3M · Buy txns: 1 · Insiders buying: 1 · Latest buy: Sep 11, 2026
· Distress Risk (Altman Z″) — Z″-Score: -0.95 · Working capital / assets: 0.22 · Retained earnings / assets: -1.30 · EBIT / assets: 0.11 · Equity / liabilities: 1.06
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 3 of the last 20 quarterly lists; latest 2023 Q4, ranked #15 of 50.
Also held by the tracked funds that hold FTK — ranked by lift, the co-holding pattern described in Methodology: Orion S.A. (OEC) · Element Solutions Inc (ESI) · ASP Isotopes Inc. (ASPI) · CABOT CORP (CBT) · Merck & Co., Inc. (MRK) · LINDE PLC (LIN) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 3, 2026 | 2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 23, 2026 | 1.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 9, 2026 | 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Orion S.A. (OEC) · Track Record: how the signals scored · Practice timing on FTK
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.